ACD PHARMACEUTICALS AS
Operating
Produksjon og salg av farmasøytiske produkter og virksomhet som står
i forbindelse med dette.
Produksjon og salg av farmasøytiske produkter.
Organization
- Chairman of the board
- PC
- Years since formation
- 27 years
- since Feb 12, 1998
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 12
Ownership
- Number of shares and share classes
- 300,000
- 1 share class
- Total number of shareholders
- 2
- companies
- Belongs to group of
Financials
- Total operating income 2024
- 24,666,319
- NOK
- Annual total result 2024
- -967,122
- NOK
- Total equity 2024
- 13,983,767
- NOK
Last update: Oct 15, 2025
Management
Board
| Name | Role | Shares |
|---|---|---|
JR 1967 | Board Member | - |
PC | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JR 1967 | - | 99.67 % indirectly |
Last update: Jun 1, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 299,000 | 99.67 % | |
| Ordinary shares | 1,000 | 0.33 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -308,556Employees: 0
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 24,666,319 | 29,422,858 | 26,850,380 | 12,705,836 |
Annual Total Result | -967,122 | 3,652,953 | -12,270,640 | 1,144,517 |
Total assets | 75,444,325 | 32,902,332 | 24,282,655 | 16,204,229 |
Total liabilities | 61,460,558 | 17,731,018 | 10,208,523 | 3,170,698 |
Total equity | 13,983,767 | 15,171,315 | 14,074,132 | 13,033,531 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 24,666,319 | 29,422,858 | 26,850,380 | 12,705,836 |
Total operating costs | 28,490,726 | 24,574,688 | 42,807,484 | 11,420,493 |
Operating result | -3,824,407 | 4,848,169 | -15,957,104 | 1,285,343 |
Financial income/costs | -717,345 | -468,716 | -36,400 | -25,605 |
Profit before tax | -4,541,752 | 4,379,453 | -15,993,504 | 1,259,738 |
Total tax & extraordinary income/cost | -3,574,630 | 726,500 | -3,722,864 | 115,221 |
Annual Total Result | -967,122 | 3,652,953 | -12,270,640 | 1,144,517 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 48,325,564 | 25,452,376 | 1,103,000 | 3,672,740 |
Total current assets | 27,118,761 | 7,449,956 | 23,179,655 | 12,531,489 |
Total assets | 75,444,325 | 32,902,332 | 24,282,655 | 16,204,229 |
Short term debt | 61,460,558 | 17,695,963 | 5,098,973 | 3,170,698 |
Long term debt | 0 | 35,055 | 5,109,550 | 0 |
Total liabilities | 61,460,558 | 17,731,018 | 10,208,523 | 3,170,698 |
Contributed capital | 13,390,815 | 13,611,241 | 13,611,241 | 300,000 |
Retained earnings | 592,952 | 1,560,074 | 462,891 | 12,733,531 |
Total equity | 13,983,767 | 15,171,315 | 14,074,132 | 13,033,531 |
Total equity and liabilities | 75,444,325 | 32,902,332 | 24,282,655 | 16,204,229 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises